HERNDON, Va., Oct. 13 /PRNewswire/ -- Trianz Business Solutions is pleased to announce that REGISTRAT-MAPI, a long term client of Acceliant eClinical suite, has agreed to serve as advisors in the development of the ePRO/mPRO module for Acceliant. REGISTRAT-MAPI has utilized Acceliant since 2007, for many of their Late Phase studies. REGISTRAT-MAPI, using their clinical experience and knowledge of the industry accumulated conducting Late Phase studies, will advise Trianz in defining and reviewing the ePRO module.
Stephen Webb, REGISTRAT-MAPI, President North America stated that, "since the majority of our late phase studies include collecting, analyzing and interpreting patient reported outcome (PRO) data to demonstrate product effectiveness and evidence based science, having these robust ePRO tools and web-based applications significantly contribute to successful conduct of these studies."
Acceliant V6.1, released earlier this year, and V6.2 scheduled for Q4 2010 release, already incorporates a number of functional enhancements identified by REGISTRAT-MAPI based on their unique PRO experience as the leading Global Late Phase CRO dedicated to 'real life' clinical research. Trianz and REGISTRAT-MAPI greatly value this mutually benefitted collaboration. The Acceliant ePRO module seamlessly integrates with the Acceliant eClinical Suite to expand the breadth of data collection channels and technology options.
Sri Manchala, President and CEO of Trianz, adds, "Acceliant ePRO supports a rich set of features for patients to register, enroll and complete the necessary forms. Data capture applications include: Web, Smart Phones, Tablets, and IVRS. Additionally, the ePRO module provides sites with patient pr